Steatohepatitis drugs are used to treat non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). These drugs are used to reduce inflammation, improve liver function, and reduce the risk of cirrhosis and liver cancer. They can also help to reduce the risk of cardiovascular disease. Commonly used steatohepatitis drugs include vitamin E, pioglitazone, obeticholic acid, and elafibranor. These drugs are part of the larger market of liver and kidney disorder drugs, which also includes drugs used to treat hepatitis, cirrhosis, and other liver and kidney diseases. Some companies in the steatohepatitis drugs market include Gilead Sciences, Intercept Pharmaceuticals, Allergan, Novartis, and Merck. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
